Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Oncologists' Views Regarding the Role of Electronic Health Records in Care Coordination.

Asan O, Nattinger AB, Gurses AP, Tyszka JT, Yen TWF.

JCO Clin Cancer Inform. 2018 Dec;(2):1-12. doi: 10.1200/CCI.17.00118.

2.

Work Schedules of Hospitalists and Continuity of Care During Hospital Stays of Texas Medicare Patients: an Observational Study.

Goodwin JS, Zhou J, Kuo YF, Nattinger AB.

J Gen Intern Med. 2018 Dec 18. doi: 10.1007/s11606-018-4777-z. [Epub ahead of print] No abstract available.

PMID:
30565152
3.

Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population-based study.

Kamaraju S, Shi Y, Smith E, Nattinger AB, Laud P, Neuner J.

Clin Cardiol. 2019 Jan;42(1):93-100. doi: 10.1002/clc.23114. Epub 2018 Dec 7.

4.

Investigating the Association Between Advanced Practice Providers and Chemotherapy-Related Adverse Events in Women With Breast Cancer: A Nested Case-Control Study.

Yen TWF, Nattinger AB, McGinley EL, Fergestrom N, Pezzin LE, Laud PW.

J Oncol Pract. 2018 Oct 10:JOP1800277. doi: 10.1200/JOP.18.00277. [Epub ahead of print]

PMID:
30303759
5.

The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer.

Kong AL, Nattinger AB, McGinley E, Pezzin LE.

Breast Cancer Res Treat. 2018 Sep;171(2):477-488. doi: 10.1007/s10549-018-4837-4. Epub 2018 Jun 5.

PMID:
29869776
6.

Association of Hospitalist Years of Experience With Mortality in the Hospitalized Medicare Population.

Goodwin JS, Salameh H, Zhou J, Singh S, Kuo YF, Nattinger AB.

JAMA Intern Med. 2018 Feb 1;178(2):196-203. doi: 10.1001/jamainternmed.2017.7049.

7.

Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D.

Charlson JA, McGinley EL, Nattinger AB, Neuner JM, Pezzin LE.

J Natl Compr Canc Netw. 2017 Dec;15(12):1509-1517. doi: 10.6004/jnccn.2017.7021.

PMID:
29223989
8.

Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer.

Yen TWF, Laud PW, Pezzin LE, McGinley EL, Wozniak E, Sparapani R, Nattinger AB.

Med Care. 2018 Jan;56(1):78-84. doi: 10.1097/MLR.0000000000000832.

9.

Socioeconomic status and breast cancer treatment.

Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE.

Breast Cancer Res Treat. 2018 Jan;167(1):1-8. doi: 10.1007/s10549-017-4490-3. Epub 2017 Sep 7. Review.

10.

Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part D.

Nattinger AB, Wozniak EM, McGinley EL, Li J, Laud P, Pezzin LE.

Med Care. 2017 May;55(5):463-469. doi: 10.1097/MLR.0000000000000685.

11.

Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.

Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM.

J Clin Oncol. 2016 Dec 20;34(36):4398-4404. Epub 2016 Oct 24.

12.

Effect of hospital volume on processes of breast cancer care: A National Cancer Data Base study.

Yen TW, Pezzin LE, Li J, Sparapani R, Laud PW, Nattinger AB.

Cancer. 2017 May 15;123(6):957-966. doi: 10.1002/cncr.30413. Epub 2016 Nov 8.

13.

A statewide controlled trial intervention to reduce use of unproven or ineffective breast cancer care.

Pezzin LE, Laud P, Neuner J, Yen TW, Nattinger AB.

Contemp Clin Trials. 2016 Sep;50:150-6. doi: 10.1016/j.cct.2016.08.005. Epub 2016 Aug 10.

14.

The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer.

Yen TW, Li J, Sparapani RA, Laud PW, Nattinger AB.

Medicine (Baltimore). 2016 Aug;95(31):e4392. doi: 10.1097/MD.0000000000004392.

15.

Time Spent Outdoors, Depressive Symptoms, and Variation by Race and Ethnicity.

Beyer KM, Szabo A, Nattinger AB.

Am J Prev Med. 2016 Sep;51(3):281-90. doi: 10.1016/j.amepre.2016.05.004. Epub 2016 Jun 16.

PMID:
27320702
16.

Breast Cancer Screening and Prevention.

Nattinger AB, Mitchell JL.

Ann Intern Med. 2016 Jun 7;164(11):ITC81-ITC96. doi: 10.7326/AITC201606070. Review.

PMID:
27270661
17.

New spatially continuous indices of redlining and racial bias in mortgage lending: links to survival after breast cancer diagnosis and implications for health disparities research.

Beyer KM, Zhou Y, Matthews K, Bemanian A, Laud PW, Nattinger AB.

Health Place. 2016 Jul;40:34-43. doi: 10.1016/j.healthplace.2016.04.014. Epub 2016 May 9.

PMID:
27173381
18.

Breast and Colorectal Cancer Survival Disparities in Southeastern Wisconsin.

Beyer KM, Zhou Y, Matthews K, Hoormann K, Bemanian A, Laud PW, Nattinger AB.

WMJ. 2016 Feb;115(1):17-21.

19.

Reexamining the Relationship of Breast Cancer Hospital and Surgical Volume to Mortality: An Instrumental Variable Analysis.

Pezzin LE, Laud P, Yen TW, Neuner J, Nattinger AB.

Med Care. 2015 Dec;53(12):1033-9. doi: 10.1097/MLR.0000000000000439.

20.

Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations.

Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM.

Springerplus. 2015 Sep 21;4:531. doi: 10.1186/s40064-015-1233-y. eCollection 2015.

Supplemental Content

Loading ...
Support Center